Skye Bioscience, Inc. — Director's Dealing 2017

Mar 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2017-03-13

Reporting Person: Lapham Reg Alexander (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-13	Common Stock	X	119700	$1.00	Disposed	3787500	Direct

Footnotes

F1: The shares of common stock were transferred to a creditor as repayment of outstanding principal and accrued interest of certain promissory note upon maturity pursuant to the terms of such note.